Kyle Amber to Treatment Outcome
This is a "connection" page, showing publications Kyle Amber has written about Treatment Outcome.
Connection Strength
0.207
-
A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug; 21(4):557-565.
Score: 0.096
-
Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524.
Score: 0.091
-
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808.
Score: 0.020